NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
02/25/2026
Back to search
Official data from USPTO
PHASE CLINICAL SERVICES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
02/26/2026
Trademark type
Combined
Nice classes
35, 42, 45
Filing date
09/20/2019
Registration date
05/05/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/25/2026
Last transaction
02/26/2026
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
First use anywhere
02/26/2019
First use in commerce
04/04/2019
Drawing code
3
Owner type
16
Owner location
New York, NY, US
Examiner
LEE, OLIVIA SUNMIN
Current location
Historical data usage
Mark description
The mark consists of a square outline with two curved corners containing inside three diagonally arranged filled-in squares with each square exhibiting a separate border, next to the wording "Phase Clinical Services".
Holders and representatives
Holders
CTH Biotech LLC
Representatives
CTH Biotech LLC
Technical classification
Nice Classes
Class 35Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; Business consulting and management in the field of clinical trialsmanagement and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trialsproviding information management services; Providing independent review of clinical trials for business purposes; Recruitment advertisement servicesposting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs
Class 42
Blood analysis services; Scientific and technological servicesscientific research in the field of drug development; Compiling data for research purposes in the field of medical science and medical consultancy; Conducting clinical trials for others; Conducting clinical trials for others in the field of oncology; Consulting services for others in the field of designplanningimplementation project management of clinical trials; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific researchconducting clinical trials for others; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Class 45
Providing independent review of clinical trials involving human subjectsreviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research
Publications
History of USPTO decisions and trademark events.
22 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
02/25/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/23/2026
ES8R
TEAS SECTION 8 RECEIVED
10/03/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/05/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
05/05/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/18/2020
PUBO
PUBLISHED FOR OPPOSITION
02/18/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/29/2020
ALIE
ASSIGNED TO LIE
01/14/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/10/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
01/08/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/08/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
01/08/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/08/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/21/2019
GNRT
NON-FINAL ACTION E-MAILED
12/21/2019
CNRT
NON-FINAL ACTION WRITTEN
12/21/2019
DOCK
ASSIGNED TO EXAMINER
12/19/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/28/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/27/2019
NWAP
NEW APPLICATION ENTERED
09/24/2019
Continuous trademark protection
Get notified about every new filing that threatens PHASE CLINICAL SERVICES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.